Fulgent Genetics Inc (FLGT)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $688.98M
Last updated: Nov 17, 2026 at 11:06 AM ET
Fulgent Genetics Inc (FLGT) Valuation Multiples
Fulgent Genetics (FLGT) trades at 2.0x sales and 0.7x book value. Its P/S of 2.0x is in line with its 5-year median. Its forward P/E is 7.7x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 7.7x |
| Price to sales | 2.0x |
| Price to book | 0.7x |
| PEG | N/A |
| FCF yield | -0.2% |
Historical Medians
Against its 10-year medians, its P/S is 28.6% below 2.8x and its P/B is 46.2% below 1.3x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 2.0x | 2.0x | 2.8x |
| P/B | 0.7x | 0.6x | 1.3x |
Valuation History
Over the 6 of the 10 year ends shown that have a P/E, its P/E ranged from 5.5x in 2022 to 71.7x in 2019.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $26.27 | 64.1x | 2.5x | 0.7x |
| 2024 | $18.47 | 37.7x | 2.0x | 0.5x |
| 2023 | $28.91 | N/A | 3.0x | 0.8x |
| 2022 | $29.78 | 5.5x | 1.5x | 0.7x |
| 2021 | $100.59 | 6.1x | 3.0x | 2.7x |
| 2020 | $52.10 | 6.2x | 3.1x | 2.5x |
| 2019 | $12.90 | 71.7x | 7.4x | 3.1x |
| 2018 | $3.17 | N/A | 2.7x | 1.1x |
| 2017 | $4.38 | N/A | 4.1x | 1.4x |
| 2016 | $11.57 | N/A | 9.2x | 3.8x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About FLGT
What is FLGT's forward P/E ratio?
Fulgent Genetics has a forward P/E ratio of 7.7x.
Is FLGT stock overvalued?
GNG's valuation label for FLGT is Fairly valued.
What is FLGT's price to sales ratio?
Fulgent Genetics has a price to sales ratio of 2.0x.
FLGT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts